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Oral Pathology: Gene Expression 
in Odontogenic Cysts
Naida Hadziabdic and Amina Kurtovic-Kozaric
Abstract
Odontogenic cysts are a group of common pathological lesions of the jaw. 
Typically, they can be found randomly on X-rays as round benign lesions. 
However, some of them can behave aggressively with a tendency toward malig-
nancy. Among odontogenic cysts with benign pathology, up to 60% of all jaw 
cysts are radicular cysts, which originate from root canal infection. Pathogenesis 
involves the interaction between osteoblasts, osteocytes, and osteoclasts as well 
as the expression of RANK-RANKL/OPG signaling system. Furthermore, collage-
nases (e.g., MMPs) are expressed in epithelial lining of the cyst. Among odonto-
genic cysts with potentially aggressive behavior, odontogenic keratocysts (OKCs) 
have a high rate of recurrence and very debatable treatment options; they can 
be associated with Gorlin syndrome. Keratocysts have developmental origin and 
show variability in their gene expression profiles. Their etiology is closely related 
to genetic factors, especially mutations in different members of Shh signaling 
pathway, including PTCH gene.
Keywords: odontogenic cysts, radicular cyst, keratocyst, RANK-RANKL/OPG, 
PTCH gene
1. Introduction
Odontogenic cysts are pathological cavities located in the jaw bones, filled with 
fluid surrounded by epithelial lining and fibrous connective tissue. Two most com-
mon odontogenic cysts with epithelial lining are inflammatory and developmental 
cysts (Figure 1). Among inflammatory cysts, the most characteristic one is the 
radicular cyst, which can be found in 60% of all odontogenic cysts. Radicular cyst 
originates from root canal infection and is of benign nature [1]. Cysts that originate 
from tissues involved in tooth development are called developmental cysts. Among 
them, the most interesting one is odontogenic keratocyst because of its unique and 
unexplored characteristics [2].
This chapter will deal with gene expression profiles of radicular cysts as the 
most common member of odontogenic cysts and keratocysts as the most debatable 
member of epithelial developmental cysts in order to uncover possible mechanism 
of pathogenesis of these two types of jaw cysts.
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2. Radicular cysts
2.1 Radicular and residual cysts
Radicular cysts are inflammatory cyst of jaw bones developing as a result of 
proliferation of the epithelium on the site of inflammation. They are the types of 
inflammatory lesions, which develop from epithelial residues of Hertwig lining in 
the process of periapical periodontitis after pulp necrosis. Cysts, which develop like 
this, are predominantly located around root apex and/or on the lateral side of the 
root, and in that case, they are called lateral radicular cysts. It often happens that 
radicular cyst remains in jaw bones after removal of the offending tooth, and in that 
case, it is called as residual cyst [1].
Radicular and residual cysts are by far the most common cystic lesions in the 
jaws, comprising 30% of all odontogenic cysts over a 30-year period according to 
results published by Jones et al. [3]. According to the age distribution of radicular 
cysts, most occur in patients who are in the third decade of life [3, 4]. There are 
many cases of patients who are between 40 and 60 years old, and after that, the 
number of cases decreases. Only few cases are seen in children even though dental 
caries commonly occurs in children.
Numerous studies have shown that radicular cysts occur more often in men than 
in women. The lower frequency in women may be because they take more care about 
mouth hygiene, especially the maxillary anterior incisors, where occurrence of cysts is 
very common. However, trauma to maxillary anterior teeth usually occurs to men [3].
Generally, radicular cysts show no symptoms and are discovered only after tak-
ing periapical radiographs of teeth with non-vital pulps. However, radicular cyst is 
the most common cause of swelling of the jaws, which patients often complain for. 
In the beginning, the enlargement is bony hard but as the cyst grows, the covering 
bone becomes very thin, and the swelling exhibits “egg shell crackling” or “springi-
ness.” The lesion becomes fluctuant only when the cyst has completely eroded the 
bone. In the mandible there is labial or buccal enlargement, rarely lingual, whereas 
in the maxilla, it is usually buccal or palatal [1].
Among other symptoms, pain and infection are very common in radicular cysts. 
Unless there is an infection, patients with radicular cyst usually feel no pain. But, 
it seems like there is no correlation between symptoms and infection. In the study 
done by Vier and Figueiredo, 21 out of 24 cysts were described as cavities which are 
filled with pus [5]. Authors did not correlate this finding and clinical symptoms, but 
it is unlikely that there is a relationship because most cysts are symptomless. In some 
cases patients complain of pain even though there is no evidence of infection and no 
Figure 1. 
Modified classification of cysts found in oral and maxillofacial regions [1].
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evidence of acute inflammation is present histologically after the cyst is removed [5]. 
On the other hand, some patients have histologically inflamed and clinically infected 
cysts, but they feel no pain [6]. A number of authors believe that there are cyst-prone 
individuals who are susceptible to developing radicular cysts because it often happens 
that more than one cyst is seen in one patient [7]. This can be supported and explained 
by the fact that occurrence of cysts is rare in relation to the large numbers of carious 
teeth which have dead pulps. Possibly, an immune mechanism inhibits formation of 
the cyst in most individuals, and patients who are prone to cyst development have a 
defect in suppression mechanism and immunological surveillance [8]. There is a pos-
sibility that some individuals are genetically susceptible to radicular cyst development.
Residual radicular cysts are cysts which remain after the non-vital offending 
tooth is removed. Studies have shown that they represent approximately 10% of 
all odontogenic cysts [9, 10]. In the study, Nair et al. considered that the type of 
cyst was important because of its persistence after treatment [11]. His findings 
confirmed the work of Simon [12] who stated that there were two types of radicular 
cyst: true radicular cyst, which contains a closed cavity lined by the epithelium, and 
the periapical pocket cyst in which the epithelium is attached to the margins of the 
apical foramen, so that the cyst lumen stays open to the root canal which is affected. 
Pocket cyst heals after treatment and tooth extraction, but true cyst, which is com-
pletely enclosed, is self-sustaining and persists even if there is no cause present [12].
2.2 Pathogenesis of radicular cysts
The pathogenesis of radicular cysts can be separated into three phases: the phase 
of initiation, the phase of cyst formation, and the phase of enlargement. Many 
studies have been done to investigate the mechanisms which are involved into these 
three phases.
2.2.1 The phase of initiation
Scientists agree that the epithelial cell rests of Malassez found in the periodontal 
ligament in periapical granulomas which are connected to necrotic and inflamed 
pulps are, in fact, the source of cyst linings [13]. The epithelial cell rests begin to 
multiply by inflammation which results from bacteria and debris discharged from 
the dead pulp. Bacterial endotoxins released from the necrotic pulp may be the key 
factor which initiates the inflammation and immune response and cause epithelial 
proliferation [1]. Meghji et al. investigated cyst fluids and grew cyst explants from 
radicular cysts and other cyst types and revealed that there are higher levels of 
endotoxins in radicular than in the other cysts [13].
Immunological studies are crucial in further understanding of granulomas and 
cysts, and they indicate that humoral and cell-mediated processes are involved in 
the pathogenesis of these lesions. Immunological studies have also demonstrated 
that inflammatory cytokines have an important role in the proliferation of epithelial 
cell rests. Stern et al. demonstrated that T lymphocyte infiltrates are involved in 
the development of periapical granulomas [1]. After a large number of studies, it 
became clear that endotoxins and inflammatory cytokines are highly involved in 
stimulation of the epithelial proliferation and they function as chemotactic and 
pro-inflammatory molecules as well [14, 15].
2.2.2 Phase of cyst formation
Pathogenesis of a radicular cyst is the next phase of cyst development, and 
it involves the process of cavity being lined by odontogenic epithelium. Two 
theories have been proposed, and both of them are reasonable and may function 
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independently. The primarily accepted theory proposes that epithelial cells multiply 
and enclose the surface of connective tissue of an abscess cavity or cavity, which 
resulted from the breakdown of connective tissue by activity of proteolytic enzymes 
[16]. The secondary one, which is supported more, states that radicular cyst forms 
inside of the multiplying epithelial mass in periapical granuloma by cell death in the 
center (Figure 2) [16].
2.2.3 Growth and enlargement of the radicular cyst
The cyst enlargement is the final stage in radicular cyst pathogenesis. Toller’s 
studies showed that osmosis contributes to the increase in the size of cysts [17]. 
Ward et al. proved this by simulating the growth of odontogenic cyst by mathemati-
cal modeling [18]. This modeling not only confirmed the results of Kubota et al. but 
also demonstrated that as the cyst became larger, cell proliferation played bigger 
part than osmotic pressure [19]. Harris and Toller suggested that cyst enlargement 
depends on epithelial proliferation which continues if inflammatory stimulus is 
present [20]. Figure 3 shows large radicular cyst in the upper jaw.
2.3 Gene expression in radicular cysts
As described previously, among odontogenic cysts with benign pathology, up to 
60% of all jaw cysts are radicular cysts, which originate from root canal infection 
caused by various microorganisms. The consequence of the radicular cyst development 
is the concomitant resorption of the surrounding bone tissues and periradicular peri-
odontal ligament (PDL; [21]). Studies that have analyzed gene expression in radicular 
Figure 2. 
Schematic representation of the development of radicular cyst. Starting from the left, superficial caries 
forms first, followed by medium and deep caries. Untreated deep caries leads to total pulp inflammation. 
Subsequently, necrosis of the pulp appears, which becomes infected. The resulting infection of the root canal 
initiates the epithelial remnants of Hertwig sheath (Malassez epithelial rests) to proliferate. Once the cells 
proliferate, the epithelial nest is formed. When the epithelial nest reaches the size of 1 cm, the center becomes 
necrotic leading to the formation of future cystic cavity, which becomes lined with the epithelium. For unknown 
reasons, this epithelium starts secreting fluid, which is called cystic fluid. These steps lead to the formation of 
radicular cyst, a round cavity filled with fluid and lined with the epithelium and fibrous connective tissue. This 
description of the radicular cyst development is the prevailing theory.
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cysts have mostly focused on genes that are involved in processes such as bone metabo-
lism, inflammation, and tumorigenesis. Regarding bone metabolism, a gene known as 
receptor activator of nuclear factor-B ligand (RANKL) has been extensively studied 
because of its role in bone resorption around the tooth apex. This gene is part of a 
pathway that activates osteoclasts and is inhibited by a protein called osteoprotegerin 
(OPG). The role of RANK-RANKL-OPG signaling pathway in radicular cyst patho-
genesis is further described in Section 2.3.2. Regarding genes involved in inflammatory 
processes, studies have analyzed expression of genes that code for chemokines and 
chemokine receptors that are involved in T helper type 1 (Th1) and Th2 responses that 
are characterized by the generation of interleukin-2 (IL-2), IL-12, and interferon-c 
(IFN-c) and by IL-4, IL-5, IL-6, IL-10, and IL-13, respectively [22, 23]. Regarding 
genes involved in tumorigenesis, TP53 has been well analyzed in radicular cysts, where 
it shows low expression. Besides, TP53, PCNA, FHIT, and Ki67 genes were analyzed 
and also showed insignificant changes compared to controls [24–26].
However, the most extensively studied genes in the pathogenesis of radicular 
cysts belong to the family of matrix metalloproteinases (MMPs). Their role in the 
cyst formation and development is described in Section 2.3.1.
2.3.1 Matrix metalloproteinases (MMPs)
The family of genes that are most commonly associated with the development 
of these lesions are matrix metalloproteinases (MMPs), which are metal-dependent 
endopeptidases that represent the major class of enzymes responsible for extra-
cellular matrix degradation. It has been shown that MMPs have a crucial role in 
collagen degradation during periodontal tissue destruction [27–29]. Schematic 
representation of different classes of MMPs and an example of molecular struc-
ture is shown in Figure 4. Most commonly differentially expressed MMPs in oral 
diseases are presented in Table 1. For example, MMP-1, MMP-2, MMP-3, MMP-8, 
MMP-9, and MMP-13 play a role in the pathogenesis of periapical inflammatory 
lesions [27–31]. MMP-1 is a crucial enzyme in the initiation of osteoclastic bone 
Figure 3. 
Large radicular cyst located in the upper jaw on the right side. The appearance of the radicular cyst after 
mucoperiosteal flap was raised (A). Bone cavity after the cyst enucleation (B). The macroscopic view of the 
enucleated cyst (C). The histological morphology of radicular cyst with typical cholesterol crystals in the form 
of clefts, stained with H&E, 40× magnification (D).
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resorption [32], because it degrades the collagen of the unmineralized layer found 
on the surface of the bone. After collagen degradation, the collagen fragments are 
produced, which function in osteoclast activation [33]. Studies in rats have shown 
that MMP-1 expression is elevated in the active phase of periapical lesion develop-
ment [34]. MMP-1 also causes expansion of radicular cysts in humans [35].
MMP-2 and MMP-9 function in the degradation of the extracellular matrix 
(ECM), particularly during the active stages of lesion development [30], and their 
expression is increased in those lesions compared to control healthy tissue (gingiva, 
PDL, or oral mucosa).
MMPs play an important role in normal cellular processes such as tissue growth, 
bone resorption, and remodeling (wound healing and angiogenesis) [36]. MMPs 
are secreted in their proenzyme state and require extracellular activation. They are 
regulated by endogenously secreted inhibitors, called TIMPs (the tissue inhibitor 
of metalloproteinases). MMPs cleave native, nondenatured collagens with long 
uninterrupted triple helices and can function as collagenases (Table 1) [37]. Thus, 
the molecular basis of MMP function involves proteolytic cleavage of different sub-
strates and subsequent activation of transforming growth factor-beta (TGF-beta), 
insulin-like growth factors (IGF), vascular endothelial growth factors (VEGF), and 
RANKL pathway.
Normal tissues generally show low expression of MMPs. However, during patho-
logical states that require destruction of extracellular matrix, expression of MMPs can 
be drastically increased [29]. In normal and healthy tissues, components of extracel-
lular matrix are in constant balance between degradation and protein synthesis. It has 
been shown that elevated MMP levels correlate with nonhealing [38, 39].
In pathological state such as apical periodontitis, MMP expression and secre-
tion are increased, suggesting the direct role of MMPs in tissue remodeling and 
Figure 4. 
Schematic classification, domain, and crystal structure of MMPs. Functional classification of MMPs is shown 
in A. MMPs are classified according to their function into collagenases, gelatinases, stromelysins, membrane-
type MMPs, matrilysin, enamelin, metalloelastases, and others. Domain structure of collagenases (MMP-1, 
MMP-8, MMP-13) and gelatinases (MMP-2, MMP-9) is shown in B. The domain structure consists of signal 
peptide sequence (in blue color, labeled “pro”); prodomain that inhibits the catalytic domain, making it 
inaccessible to substrates (in pink color, labeled “pre”); catalytic domain that contains zinc atom (in green color, 
labeled “catalytic”); and hinge domain which links the catalytic and hemopexin domain (in red color, labeled 
“hemopexin”). Gelatinases also contain fibronectin-like domain repeats which aid in substrate binding (in blue 
color). Crystal structure of MMP-1 is shown in C.
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destruction during lesion development [40–42]. Regulation of their expression is 
primarily controlled at the transcriptional level even though regulatory mechanisms 
have still not been fully elucidated [27, 43, 44]. Some of the reasons include the 
influence of promoter polymorphisms, epigenetic mechanisms, and posttranscrip-
tional processes [43, 45].
Promoter polymorphisms have been detected in MMP promoter regions, sug-
gesting that the changes in MMP expression can predispose individuals to develop 
periapical inflammatory lesions. Similarly, these MMP promoter polymorphisms 
can lead to progression of disease [42, 46]. For example, Menezes-Silva et al. 
investigated genetic predisposition to periapical disease by testing 16 SNP poly-
morphisms in MMP2, MMP3, MMP9, MMP13, MMP14, and TIMP2 genes [42]. 
They found that polymorphisms in MMP2 and MMP3 genes are associated with 
the development of periapical lesions, suggesting that these markers could assist in 
prevention and healing process [42].
Besides MMP promoter polymorphisms, another regulatory mechanism for 
MMP expression has been found at the epigenetic level, where methylation of MMP 
promoters can lead to gene inactivation and subsequent decrease in transcription 
[47]. Campos et al. have studied the methylation state of MMP-2 and MMP-9 in 
periapical inflammatory lesions [48]. Their results show that MMP-2 gene was par-
tially methylated in periapical granuloma, radicular cysts, and normal oral mucosa, 
Name of enzyme Class Substrate Expression in normal tissue and oral disease
MMP-1 
(collagenase-1, 
interstitial 
collagenase)
Collagenase Collagen I, 
II, III, VII, 
VIII, and X 
and gelatin
Bone resorption in periapical lesions and human 
periapical lesions degrades nonmineralized 
extracellular matrix and stimulates 
osteoclastogenesis by collagen degradation on 
bone surface, expression in cystic wall and cystic 
fluid, pulpitis, squamocellular carcinoma, and 
normal tissues (stomach and gallbladder)
MMP-8 
(collagenase-2, 
neutrophil 
collagenase)
Collagenase Collagen 
I, II, III, V, 
VII, VIII, 
and X and 
gelatin
Chronic pulp inflammation, human periapical 
lesions, pulpitis, caries, and normal tissues (bone 
marrow and spleen)
MMP-13 
(collagenase-3)
Collagenase Collagen I, 
II, III, IV, 
V, VII, IX, 
and X
Chronic pulp inflammation, human periapical 
lesions, pulpitis, and normal tissue (vagina, lung)
MMP-9 
(gelatinase B)
Gelatinase Collagen 
III, IV, V, 
VII, X, and 
XI
Periodontitis, caries, oral squamocellular 
carcinoma metastasis, invasiveness and shorter 
survival, and human periapical lesions
MMP-2 
(gelatinase A)
Gelatinase Collagen I, 
II, III, IV, 
V, VII, X, 
and XI
Periodontitis, caries, oral squamocellular 
carcinoma metastasis, invasiveness and 
shorter survival, collagen type IV degradation, 
ameloblastoma, human periapical lesions, 
and normal tissue (gallbladder, uterine, 
endometrium, cervix)
MMP-3 Collagen 
III, IV, V, 
VII, IX, X, 
and XI
Oral squamocellular carcinoma, human periapical 
lesions, and normal tissue (endometrium, 
salivary gland)
Table 1. 
List of MMPs most commonly associated with and expressed in oral disease and healthy tissues.
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Figure 5. 
RANKL-RANK-OPG system as regulators of bone resorption. Bone metabolism is a dynamic process that 
balances bone formation and bone resorption. RANKL (ligand) is secreted by osteoblasts and binds to the 
RANK receptor on osteoclast precursors and activated osteoclasts, which in turn result in bone resorption. The 
inhibition of this process is mediated by OPG.
and subsequent association between methylation status and gene expression was 
not possible [48]. Regarding MMP-9, the study found that this gene was more 
unmethylated in periapical granulomas and radicular cysts than in healthy mucosa, 
which implies that MMP-9 mRNA expression is increased and may be epigeneti-
cally controlled [48]. Effects of DNA methylation on MMP genes can contribute to 
individual susceptibility to the development of periapical granuloma and radicular 
cysts as periapical inflammatory lesions. Moreover, it may also play a role in the 
patient’s response to therapy [48].
Besides MMP studies, other genes such as FOXP3 have shown interesting results 
in periapical granulomas and radicular cysts. It has been shown that the FOXP3 gene 
promoter methylation was inversely correlated with FOXP3 transcript levels, suggest-
ing that FOXP3 may be crucial in determining periapical lesion development [49].
In conclusion, here we presented studies that suggest that genetic predisposition 
to frequent development of periapical inflammatory lesions could be caused by the 
presence of polymorphisms in MMP gene promoters or by epigenetic mechanisms 
such as differential methylation status of MMP genes.
2.3.2 RANKL expression
RANKL-RANK-OPG system discovery has changed our understanding of bone 
biology (Figure 5). This is a signaling system that is crucial for skeletal homeostasis 
because it maintains the balance between bone resorption by osteoclasts and bone 
formation by osteoblasts. RANKL is a ligand for its receptor RANK which can be 
found on osteoclast progenitor cells. After binding, RANK-RANKL system activates 
NF-κB pathway and upregulation of NFATc1 protein, which is a master regulator 
of cytokines important for osteoclastogenesis. The disruption of RANKL-RANK 
system leads to the inhibition of bone resorption. RANKL belongs to the TNF 
superfamily of proteins. The name RANKL stands for receptor activator of nuclear 
factor-κB ligand, also known as osteoprotegerin ligand (OPGL), osteoclast dif-
ferentiation factor (ODF), TNF-related activation-induced cytokine (TRANCE), 
and TNF ligand superfamily member 11 (TNFSF11) [50, 51]. It is a homotrimeric 
protein that is membrane bound on osteoblasts and activated T cells. It can also be 
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secreted by T cells. RANKL is proteolytically cleaved by MMP-3 or MMP-7. Besides 
T cells and osteoclasts, RANKL expression can be seen in lymph nodes, thymus, 
mammary glands, spleen, and bone marrow. In tumor cells, RANKL is associated 
with migration and bone metastasis. Thus, RANKL is a key regulator of bone 
metabolism, specifically a regulator of osteoclastogenesis and osteoclastoactivation 
in a normal and pathological states [50, 51]. RANK is a receptor for RANKL and 
also a member of TNF superfamily. It is a homotrimeric transmembrane protein. Its 
expression is generally less than RANKL, and high expression is seen in mammary 
glands and cancer cells. OPG is an inhibitor of RANK-RANKL system. It stands 
for osteoprotegerin, also known as osteoclastogenesis inhibitory factor (OCIF) or 
tumor necrosis factor receptor superfamily member 11B, is a cytokine receptor of 
the TNF receptor superfamily encoded by the TNFRSF11B gene. It is a 380 amino 
acid glycoprotein that is found in soluble form as either monomer or dimer. The 
OPG dimer is crucial for RANK-RANKL inhibition because OPG dimer increases 
the affinity of OPG for RANKL.
RANKL affects the development of the periapical inflammatory lesions by activat-
ing osteoclasts, thus inducing pathological bone resorption [52]. RANKL protein 
expression was first shown in radicular cysts [53], which colocalized with osteoclasts. 
Subsequent studies analyzed transcript levels in inflammatory granulomas, which 
were increased compared to healthy PDL tissue [52]. RANKL expression was found in 
infiltrating leucocytes, specifically monocytes and dendritic cells, which were shown to 
be the main cells that secrete this protein. Another study compared RANKL and OPG 
levels in apical granulomas and radicular cysts [54], finding that both OPG and RANKL 
expressions were higher in granulomas than in cysts, but their ratio was comparable 
in these two types of periapical inflammatory lesions. Fukada and colleagues found 
that RANKL transcript levels were significantly higher in granuloma than in radicular 
cysts [55]. At the protein level, no difference was observed in RANKL and OPG levels 
in a study conducted by Fan and colleagues [56]. In a study on endodontically involved 
disease, RANKL expression was higher in lesions with more intense inflammation, but 
the ratio RANKL/OPG in relation to inflammation was not increased [57].
3. Odontogenic keratocysts
Odontogenic keratocysts (OKCs) represent a rare form of odontogenic cysts 
which originate from dental lamina remnants or eventually from the basal layer of 
upper and lower jaw oral epithelium before the odontogenesis ended. Since it was 
first described in 1876, this form of cysts grabs scientific attention mostly because 
of its developmental variabilities, histological appearance, and genetic basis [2, 58]. 
In the past few years, the World Health Organization (WHO) made an attempt to 
create more appropriate classification of these cysts. Recently, they were considered 
as keratocystic odontogenic tumors for their aggressive behavior, high mitotic rate, 
and association with genetic and chromosomal abnormalities. The newest WHO 
classification reclassifies them again as odontogenic keratocysts because PTCH1 gene 
mutations were detected, similarly to other developmental cysts such as dentigerous 
cyst [59–61]. Despite many classifications, pathologists and surgeons face difficulties 
in the establishment of proper diagnosis. This is because keratocysts cannot be clini-
cally and radiographically distinguished from other odontogenic cysts. Moreover, 
it is still debatable what the optimal therapeutic approach is in the treatment of 
keratocysts in order to prevent recidive, which is a characteristic of this disease [2].
Odontogenic keratocyst is histologically characterized with stratified squamous 
epithelium, which is five to eight layers thick with palisaded hyperchromatic basal 
cell layer and “corrugated” parakeratotic epithelial cells on luminal surface [2, 62, 63]. 
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Parakeratinization of the surface layer is one of the histological features that predicts 
recurrence together with the higher level of cell proliferative activity in the epithe-
lium, binding in the basal layer of the epithelium, supraepithelial split of the epithe-
lial lining, presence of daughter cells or also called satellite cells (Figure 6) [64].
Considering clinical and histological features together with unclear etiology and 
therapeutic strategy odontogenic keratocyst still remains debatable. Controversies 
in nature of these lesions are reflection of limited knowledge about their origin. 
Recent molecular and genetic discoveries try to elucidate these pathological entities 
and thus approach closer to better therapy modalities.
3.1 Molecular basis of odontogenic keratocysts
Odontogenic keratocysts are locally aggressive and have a tendency to recur 
over time. Keratocysts can happen sporadically or in conjunction with Gorlin-
Goltz syndrome (Gorlin syndrome, OMIM 109400) [62, 64]. Gorlin syndrome 
is an autosomally inherited disease with a germline mutation in PTCH gene, 
located on chromosome 9q22. The incidence is 1:60,000 newborns. Patients with 
this syndrome present with a spectrum of developmental abnormalities which 
affect skin, nervous system, eyes, endocrine system, and bones. Skin abnormali-
ties include basal cell carcinoma, benign dermoid cysts and tumors, palmar and 
plantar keratosis, and dermal calcinosis. Dental and bone abnormalities include 
multiple keratocysts, mild mandibular prognathism, kyphoscoliosis, and other 
vertebral defects like bifurcation of ribs, spina bifida, and others. Eye abnormalities 
include hypertelorism, wide nasal bridge, congenital blindness and strabismus. 
Neurological abnormalities include mental retardation, calcification of dura mater, 
and others. For the diagnosis of Gorlin syndrome, two major or one major and two 
minor criteria are needed [62, 64, 65].
The major criteria are as follows: multiple basal cell carcinoma or one tumor 
diagnosed before 20 years of age, histologically proven odontogenic keratocyst, 
three or more palmar or plantar pits, bilamellar calcification of the falx cerebri, 
fused or markedly splayed ribs, and first-degree relatives with Gorlin syndrome. 
The minor criteria include macrocephaly; congenital cleft lip or palate, frontal 
bossing, coarse face, or hypertelorism; other skeletal abnormalities; radiological 
deformities like bridging of the sella turcica, vertebral abnormalities, and ovarian 
fibroma; and medulloblastoma.
Figure 6. 
Macroscopic view (A) and histological morphology (B) of odontogenic keratocyst. Inflamed fibrous wall lined 
with nonspecific stratified squamous epithelium (arrow) with focally corrugated surface (arrow head). The 
presence of satellite cysts and solid islands in the cystic wall is marked with a star.
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The appearance of keratocysts in Gorlin syndrome patients can be seen in up 
to 92% of all patients. Even though it has been shown that the syndromic form 
of keratocysts contains much higher numbers of proliferating epithelial cells and 
satellite cysts within the cystic wall, pathological examination cannot differenti-
ate between syndromic and sporadic forms of this disease. Similarly, it has been 
shown that the syndromic form has higher rate of recurrence than the sporadic 
form. However, the syndromic form has shown more aggressive behavior than the 
sporadic form. Thus, radiographic appearance of multiple keratocyst formations 
should raise suspicion of a possible Gorlin syndrome [63].
PTCH1 gene produces Patched protein, which is a homolog of Drosophila seg-
ment polarity gene. It contains 23 coding exons spanning 74 kb and encoding a 1447 
amino acid receptor glycoprotein. This receptor is a part of the Hedgehog signaling 
cascade, which includes downstream proteins such as Smoothened (Smo) and 
Disheveled (Dsh). Molecular structure including schematic domain representation 
is shown in Figure 7.
PTCH is a tumor suppressor and as such requires both gene copies to be mutated 
in tumors. Thus, patients with Gorlin syndrome already have one inherited 
mutation and can acquire the second mutation easier than patients with sporadic 
form. It has been shown that mutations in this gene often occur as LOH (loss of 
heterozygosity), meaning that both copies are mutated through different genetic 
mechanisms such as deletions, mutations, gene silencing, and others. After PTCH 
mutation, keratocysts can acquire additional genetic alterations which accelerate 
tumor development. When LOH was analyzed in sporadic form, several additional 
tumor suppressor genes were affected such as TP53. The association between these 
mutations and appearance of satellite microcysts in the cystic wall is particularly 
interesting [64].
3.2 Gene expression in odontogenic keratocysts
The hallmark of odontogenic keratocysts is mutation in PTCH gene, which is 
a receptor in Sonic hedgehog signaling (Shh) pathway. This pathway is important 
for proper differentiation of embryonic cells, and mutations in this pathway lead 
Figure 7. 
Schematic representation of PTCH molecular structure. (A) Domain structure of PTCH protein with 12 
transmembrane domains (blue) and low complexity regions (pink). It contains 23 coding exons spanning 74 kb 
and encoding a 1447 amino acid receptor glycoprotein. (B) PTCH is a membrane-bound receptor for hedgehog 
protein (yellow). PTCH1 gene produces patched protein, which is a homolog of Drosophila segment polarity 
gene. This receptor is a part of the hedgehog signaling cascade, which include downstream proteins such as 
smoothened (Smo) and disheveled (Dsh).
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to abnormal cellular proliferation and differentiation, which is strongly associated 
with the development of certain tumors [66, 67]. This section will describe genes 
that are involved in pathogenesis of odontogenic keratocysts through Sonic hedge-
hog pathway (Shh). The members of this pathway include secreted SHH ligand, 
which binds to its receptor PTCH, a 12-pass transmembrane protein, as described 
previously (Figure 7). In the absence of SHH ligand, PTCH inhibits a transmem-
brane protein called Smoothened (SMO).
In odontogenic keratocysts, PTCH mutations include LOH, deletions, point 
mutations, and others. The consequence of PTCH mutations are the constitutive 
activation of Shh pathway. When PTCH is mutated and inactivated, it is expected 
that SMO would be disinhibited and thus activated. This is exactly what is found in 
odontogenic keratocysts, where Smo overexpression has been shown by transcrip-
tional and immunohistochemical studies [67–69]. Besides overexpression of SMO 
and PTCH, other downstream genes such as GLI1, CCND1, and BCL-2 have been 
shown to be overexpressed in odontogenic keratocysts, indicating that these SHH 
pathway genes contribute to the development of these lesions.
Another downstream target of Shh signaling is a transcription factor SOX-2 
[70] that is expressed in progenitor cells in epithelial tissues. SOX-2 expression is 
associated with elements of tooth development, especially in the region of the third 
molars in the lower jaw, which is the place where OKCs are usually located [71, 72].
Besides studies on Shh pathway, a list of genes that are upregulated in odonto-
genic keratocysts is shown in Table 2. Bioinformatic analysis has shown that other 
genes, such as TP53 and PCNA, appear as the leaders and initiators of gene expres-
sion that is important for the development of odontogenic keratocysts [61, 73, 74]. 
Their analysis has shown that genes related to cell cycle and apoptosis are often 
dysregulated in these cysts, implying the recurrence of these cysts. Studies have 
shown that TP53, PCNA, p63, and Ki-67 expression is higher in keratocysts than 
in other types of odontogenic cysts. TP53 is a tumor suppressor gene with several 
different functions in the cell including apoptosis, cell cycle arrest, and DNA repair.
The second gene that is found to be associated with odontogenic keratocysts is 
proliferating cell nuclear antigen (PCNA), which encodes a protein located in the 
nucleus and associated with DNA polymerase delta. It acts as a homotrimer and is 
Gene name Method of detection References
PCNA IHC [74]
CCND1 IHC and real-time PCR [67]
IL-6 IHC [75]
VEGFA IHC [76]
BCL2 IHC, real-time PCR, Western blot [77]
FHIT IHC [25]
GLI1 IHC [78]
TP63 IHC [76]
KRT6B IHC [79]
TP53 Bioinformatic analysis [73]
SMO IHC and transcriptional analysis [67–69]
IHC, immunohistochemistry; PCR, polymerase chain reaction.
Table 2. 
Genes that show high expression in odontogenic keratocysts, detected either at the RNA or protein level 
(modified from [63]).
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implicated in the leading strand synthesis during DNA replication. DNA damage 
induces ubiquitination of this protein through RAD6-dependent DNA repair path-
way. Expression of both TP53 and PCNA in different odontogenic lesions was higher 
in the suprabasal layer of keratocysts than in radicular cyst. Overexpression of PCNA 
in the suprabasal layer implies its neoplastic nature and a tendency toward recurrence.
4. Conclusion
This chapter summarizes gene expression profiles of radicular cysts as the most 
common member of odontogenic cysts and keratocysts, a specific entity of epithe-
lial developmental cysts, in order to uncover possible mechanism of pathogenesis 
that would help in the timely diagnosis and discovery of novel therapeutic options 
for these two types of jaw cysts. Pathogenesis of radicular cysts is associated with 
differential expression of genes involved in bone metabolism (RANK-RANKL-OPG 
pathway) and inflammation (chemokines and their receptors). However, the most 
extensively studied genes in the pathogenesis of radicular cysts belong to the family 
of matrix metalloproteinases (MMPs), which show increased expression.
Specific entities of odontogenic cysts are odontogenic keratocysts, which are 
prone to recidive. This trait of keratocysts to recur makes them similar to tumors, 
which can be also seen in their gene expression profiles. The hallmark of odonto-
genic keratocysts is mutation in PTCH gene, which is a receptor in Sonic hedgehog 
signaling (Shh) pathway. Mutations in PTCH gene lead to the constitutive activa-
tion of this pathway. Besides overexpression of PTCH, other downstream genes 
such as SMO, GLI1, CCND1, and BCL-2 have been shown to be overexpressed in 
odontogenic keratocysts, indicating that these SHH pathway genes contribute to the 
development of these lesions.
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